Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F3N7X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,291
Award facts
- Contract value 100% obligated
- $25,290.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $25,290.67 delivery order to AmerisourceBergen Drug Corp for COSENTYX (secukinumab) 300mg dose auto-injector pens on December 5, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 8, 2025. No set-aside designation was applied to this award.
COSENTYX is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This delivery order supports the Defense Health Agency and military healthcare systems' pharmaceutical supply chain requirements. AmerisourceBergen's SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its established capability to fulfill complex medical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26F3N7X?
SPE2DR26F3N7X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F3N7X worth?
The government has obligated $25,291 on SPE2DR26F3N7X.
Is contract SPE2DR26F3N7X an order under another contract?
Yes. SPE2DR26F3N7X is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3N7X competed?
The extent of competition for SPE2DR26F3N7X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award